A US medical device company with a product designed to help patients at risk of heart failure has received $196 million in new finance to support the commercialisation of a wearable defibrillator product. Kestra Medical Technologies Inc, which is located in Kirkland, Washington, with a presence in Ireland, is a privately-held company established in 2014.
